Comparison of I-131 radioimmunotherapy tumor dosimetry: Unit density sphere model versus patient-specific monte carlo calculations

Cancer Biotherapy and Radiopharmaceuticals

Volumn 26, Issue 5, 2011, Pages 615-621

  Howard, David M ^a   Kearfott, Kimberlee J ^a   Wilderman, Scott J ^b   Dewaraja, Yuni K ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Monte Carlo dosimetry; radiation dosimetry; radioimmunotherapy; SPECT

Indexed keywords

TOSITUMOMAB I 131;

ACCURACY; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; DOSIMETRY; DRUG ABSORPTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MEAN RESIDENCE TIME; MONTE CARLO METHOD; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RADIOACTIVITY; RADIOIMMUNOTHERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL MODEL; TREATMENT PLANNING; UNIT DENSITY SPHERE MODEL;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; MONTE CARLO METHOD; RADIATION DOSAGE; RADIOIMMUNOTHERAPY; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80054712314     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.0965     Document Type: Article

References (20)

1. Kaminski MS, Tuck M, Estes J, et al. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med 2005;352:441.
2. Vose JM, Wahl RL, Saleh M, et al. Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol 2000;18:1316.
3. Loevinger R, Budinger TF, Watson EE. MIRD Primer for Absorbed Dose Calculations; New York: Society of Nuclear Medicine, 1991.
4. Snyder WS, Ford MR, Warner GG, et al. MIRD Pamphlet 11: "S," Absorber Dose Per Unit Cumulated Activity For Selected Radionuclide and Organs. New York: Society of Nuclear Medicine, 1975.
5. Cristy M, Eckerman KF. Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. Oak Ridge, TN: Oak Ridge National Laboratory, ORNL/TM-8381 V1-V7;1987.
6. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005;46:1023.
7. Stabin MG, Konijnenberg MW. Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes. J Nucl Med 2000;41:149.
8. Johnson TK. MABDOS: A generalized program for internal radionuclide dosimetry. Compu Methods Prog Biomed 1988; 27:159.
9. Yoriyaz H, Stabin MG, dos Santos A. Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry. J Nucl Med 2001;42:662.
10. Sgouros G, Squeri S, Ballangrud AM, et al. Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody. Assessment of tumor dose-response. J Nucl Med 2003;44:260.
11. Dewaraja YK, Wilderman SJ, Koral KF, et al. Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: A pilot patient study. Cancer Biother Radiopharm 2009;24:417.
12. Dewaraja YK, Schipper MJ, Roberson PL, et al. 131I-tositumomab radioimmunotherapy: Initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling. J Nucl Med 2010;51:1155.
13. Wilderman SJ, Dewaraja YK. Method for fast CT/SPECT based 3D Monte Carlo absorbed dose computations in internal emitter therapy. IEEE Trans Nucl Sci 2007;54:146.
14. Bolch WE, Bouchet LG, Robertson JS, et al. MIRD Pamphlet No. 17: The Dosimetry of Nonuniform Activity Distributions-Radionuclide S Values at Voxel Level. J Nucl Med 1999; 40:11.
15. Loudos G, Tsougos I, Boukis S, et al. A radionuclide do-simetry toolkit based on material-specific Monte Carlo dose kernels. Nuc Med Commun 2009;30:504.
16. Johnson TK, Colby SB. Photon contribution to tumor dose from considerations of 131I radiolabeled antibody uptake in liver, spleen, and whole body. Med Phys 1993;20:1667.
17. Divoli A, Chiavassa S, Ferrer L, et al. Effect of patient morphology on dosimetric calculations for internal irradiation as assessed by comparisons of Monte Carlo versus conventional methodologies. J Nucl Med 2009;50:316.
18. Schipper MJ, Avram AM, Kaminski MS, et al. I-131 Radio-immunotherapy: Prediction of tumor level therapy absorbed dose from the tracer study via a mixed model fit of time-activity. Annual Meeting of the Society of Nuclear Medicine. J Nucl Med 2010;51:23.
19. Hartmann Siantar CL, DeNardo GL, DeNardo SJ. Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapy. J Nucl Med 2003;44:1322.
20. Prestwich WV, Nunes J, Kwok CS. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. J Nucl Med 1989;30:1036.